Application Nr Approved Date Route Status External Links
NDA208271 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage • Relistor Is An Opioid Antagonist. Relistor Tablets And Relistor Injection Are Indicated For The Treatment Of Opioid-Induced Constipation (Oic) In Adults With Chronic Non-Cancer Pain, Including Patients With Chronic Pain Related To Prior Cancer Or Its Treatment Who Do Not Require Frequent (E.g., Weekly) Opioid Dosage Escalation. ( 1.1 ) • Relistor Injection Is Indicated For The Treatment Of Oic In Adults With Advanced Illness Or Pain Caused By Active Cancer Who Require Opioid Dosage Escalation For Palliative Care. ( 1.2 ) 1.1 Opioid-Induced Constipation In Adult Patients With Chronic Non-Cancer Pain Relistor Tablets And Relistor Injection Are Indicated For The Treatment Of Opioid-Induced Constipation (Oic) In Adult Patients With Chronic Non-Cancer Pain, Including Patients With Chronic Pain Related To Prior Cancer Or Its Treatment Who Do Not Require Frequent (E.g., Weekly) Opioid Dosage Escalation. 1.2 Opioid-Induced Constipation In Adult Patients With Advanced Illness Relistor Injection Is Indicated For The Treatment Of Oic In Adult Patients With Advanced Illness Or Pain Caused By Active Cancer Who Require Opioid Dosage Escalation For Palliative Care.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Methylnaltrexone Bromide METHYLNALTREXONE BROMIDE ZINC5764759

Comments